Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Free-floating long-term vascularized mesenchymal organoids. | iScience | 2026 | 41568151 | PubTator, text mining | PubMed |
| Hepatocyte-hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implications. | Hepatol Commun | 2026 | 41564388 | PubTator, text mining | PubMed |
| Engineered atopic dermatitis models for recreating hypoxic conditions in atopic dermatitis microenvironments. | Bioact Mater | 2026 | 41551767 | PubTator, text mining | PubMed |
| Chemoresistance: The hidden barrier in cancer treatment. | Cancer Pathog Ther | 2026 | 41550358 | PubTator, text mining | PubMed |
| <p>Tumor microenvironment in bone sarcomas: Implications for immunotherapy and emerging therapeutic vulnerabilities (Review)</p>. | Oncol Rep | 2026 | 41543186 | PubTator, text mining | PubMed |
| <p>Beyond hepatic stellate cell heterogeneity: Resolving fibrosis, restoring regeneration (Review)</p>. | Int J Mol Med | 2026 | 41543176 | PubTator, text mining | PubMed |
| An Immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma. | J Immunother Cancer | 2026 | 41539687 | PubTator, text mining | PubMed |
| Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling. | Cell Death Dis | 2026 | 41535257 | PubTator, text mining | PubMed |
| Fertility under fire: how chemotherapy harms the ovaries and the science fighting back? | J Ovarian Res | 2026 | 41501826 | PubTator, text mining | PubMed |
| LOXL2⁺ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: Insights from multi-omics and epidemiological analyses. | Neoplasia | 2026 | 41496273 | PubTator, text mining | PubMed |
| The role of the LOX family in cancer. | Eur J Cell Biol | 2026 | 41496180 | PubTator, text mining | PubMed |
| LOXL2 and SYVN1 cooperate across cellular compartments to drive liver hepatocellular carcinoma progression. | Biochem Biophys Res Commun | 2026 | 41447886 | PubTator, text mining | PubMed |
| FGF-23 facilitates osteosarcoma metastasis by modulating the miR-4463/LOXL2 axis expression via the ERK, p38, and JNK signaling pathway. | Int J Med Sci | 2026 | 41399365 | PubTator, text mining | PubMed |
| Biomechanical and inflammatory pathways underlying the genetic architecture of keratoconus: A genomic SEM study. | Exp Eye Res | 2026 | 41308946 | PubTator, text mining | PubMed |
| Covalent Inhibitor Screening for Targeting LOXL2: Studied by Virtual Screening and Experimental Validation. | Recent Pat Anticancer Drug Discov | 2026 | 39757678 | PubTator, text mining | PubMed |
| LOXL2 labels inflammation-associated myofibroblasts predicting kidney allograft dysfunction and fibrosis. | Front Immunol | 2025 | 41607781 | PubTator, text mining | PubMed |
| Skin-lung axis in the atopic march: The immune link from skin to lungs. | Chin Med J Pulm Crit Care Med | 2025 | 41551010 | PubTator, text mining | PubMed |
| LOXL2 alleviates post-traumatic knee osteoarthritis and pain. | J Orthop Translat | 2025 | 41542103 | PubTator, text mining | PubMed |
| GPR4 promotes immune exclusion in colon cancer through LOXL2-mediated extracellular matrix remodeling. | Nat Commun | 2025 | 41436455 | PubTator, text mining | PubMed |
| Identification of Novel Biomarkers and Potential Therapeutic Targets for Systemic Sclerosis: An Integrated Analysis of Plasma Proteome-Wide Mendelian Randomization and Transcriptome. | J Inflamm Res | 2025 | 41431733 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=4